Physician profile
Maria E Lofstead
NPI 1881985950
$1,740.40
in general payments reported to CMS, 2019-2025
19 companies · $35.77 in 2025
The $35.77 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $47.36 · 2021: $373 · 2022: $360 · 2023: $405 · 2024: $39.60 · 2025: $35.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $479.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $448.83 | 2019-2023 | Repatha, Otezla |
| Abbvie INC. | $346.05 | 2019-2025 | |
| Novo Nordisk INC | $241.64 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $158.60 | 2019-2023 | Farxiga, Breztri |
| Pfizer INC. | $123.49 | 2019-2023 | |
| Glaxosmithkline, LLC. | $61.13 | 2019-2023 | Arexvy, Trelegy Ellipta, Shingrix |
| Abbott Laboratories | $55.34 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.02 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $44.62 | 2019 | |
| Astellas Pharma US INC | $32.84 | 2019-2020 | |
| Lilly USA, LLC | $31.01 | 2019-2023 | Mounjaro |
| Janssen Pharmaceuticals, INC | $25.77 | 2019 | |
| Axsome Therapeutics, INC. | $21.93 | 2023 | Auvelity |
| Idorsia Pharmaceuticals US INC | $19.83 | 2023 | Quviviq |
| Esperion Therapeutics, INC. | $19.31 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $17.73 | 2022 | |
| Merck Sharp & Dohme LLC | $17.08 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $14.53 | 2022 | |
| Jazz Pharmaceuticals INC. | $12.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Lofstead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.